Home Press Release World’s First Dual-Console Complex Robotic Beating-Heart TECAB Surgery Performed in India using Made in India technology
Press Release

World’s First Dual-Console Complex Robotic Beating-Heart TECAB Surgery Performed in India using Made in India technology

Share
World’s First Dual-Console Complex Robotic Beating-Heart TECAB Surgery Performed in India using Made in India technology
World’s First Dual-Console Complex Robotic Beating-Heart TECAB Surgery Performed in India using Made in India technology
Share

The landmark beating-heart TECAB procedure performed at Medanta Hospital using SSI Mantra system, demonstrates advances in Indian Medtech industry and the potential of dual-console technology in complex, minimally invasive heart procedures.

New Delhi: 19th, November 2026: India has achieved a global milestone in robotic cardiac surgery with the successful completion of the World’s first dual-console, five-arm robotic beating-heart Totally Endoscopic Coronary Artery Bypass (TECAB) surgery using the SSI Mantra Surgical Robotic System at Medanta, Gurugram.

The procedure was performed by Dr. Nitin Kumar Rajput, Associate Director of Robotic and Minimally Invasive Cardiac Surgery at Medanta, Gurugram and Dr. Lalit Malik, Chief Cardiac Surgeon at Manipal Hospital, Jaipur under the supervision of Dr. Sudhir Srivastava, widely considered as Father of Robotic Surgery In India, using two separate control consoles. The surgeons operated in synchronisation to perform the complex procedure with all five robotic arms of SSI Mantra system, deployed simultaneously in a dual-console configuration. A heart stabilisation system helped steady the target area while the heart continued to beat.

TECAB is a highly complex form of coronary artery bypass surgery performed through small incisions, without opening the chest, unlike a conventional sternotomy. In conventional procedures, one surgeon often needs to assist the other by operating the retractor or mobilising tissues to obtain a clear surgical view. However, under this technique with a five-arm robotic configuration and dual-console control it enables more precise movements and better coordination. This level of precision can make a significant difference to the overall clinical outcomes, benefiting both the surgeon and the patient. The beating-heart approach allows surgeons to perform the bypass while the heart continues to beat, without using a heart-lung machine.

The procedure also brings attention to the potential recovery benefits of minimally invasive robotic cardiac surgery. In this case, the patient’s recovery progress over 15 days provides an important reference point for assessing the outcomes of the approach. The outcome represents an encouraging development in robotic cardiac surgery, where advances in surgical techniques and technology continue to expand treatment possibilities for patients.

Dr. Naresh Trehan, Chairman and Managing Director, Medanta, said “This achievement reflects Medanta’s commitment to advancing cardiac care through innovation, surgical excellence and technology. The successful completion of this highly complex beating-heart TECAB procedure demonstrates how robotic surgery can make advanced cardiac interventions less invasive for patients. It is a proud moment for our team and an important step forward for cardiac surgery in India.

Dr. Sudhir Srivastava, Founder, Chairman and CEO, SS Innovations International, Inc., said, “With our vision of ‘Make in India, for the World’, this historic procedure demonstrates the capabilities of the SSI Mantra Surgical Robotic System in enabling advanced minimally invasive cardiac surgery. The successful use of dual-console control and five robotic arms in a beating-heart TECAB procedure marks a significant milestone for Indian innovation in surgical robotics. Our mission is to make world-class robotic surgery accessible and affordable and this achievement brings us a step closer to that goal.”

Dr. Nitin Kumar Rajput, Associate Director of Robotic and Minimally Invasive Cardiac Surgery at Medanta, Gurugram said, “Performing a complex beating-heart bypass procedure using five robotic arms and two control consoles requires precision, coordination and close collaboration between the surgeons. This approach allowed us to work in synchronisation throughout the procedure. The patient’s recovery following surgery was encouraging and reinforces the potential of minimally invasive techniques in advancing cardiac care.”

Dr. Lalit Malik, Chief Cardiac Surgeon, Manipal Hospital, Jaipur, said, “This procedure marks an important step in the evolution of robotic cardiac surgery. The dual-console setup enabled coordinated control between the two surgeons, while the five-arm configuration supported the technical demands of the operation. Such advancements can help expand the possibilities of minimally invasive cardiac procedures and improve the overall surgical experience for patients.”

The achievement underscores India’s growing capabilities in advanced medical technology. Developed in India by SS Innovations, the SSI Mantra Surgical Robotic System reflects the ‘Make in India, for the World’ vision, highlighting the potential of indigenous s innovation to advance complex cardiac procedures and serve global healthcare needs. The dual console surgery also provides great on job training for the second surgeon, providing him the learning curve, which was otherwise was an impossible ask.

About SS Innovations International, Inc.
SS Innovations International, Inc. (Nasdaq: SSII) develops innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible to a larger segment of the global population. The Company’s product range includes its proprietary “SSI Mantra” surgical robotic system and its comprehensive suite of “SSII Mudra” surgical instruments, which support a variety of surgical procedures including robotic cardiac surgery.  An American company headquartered in India, SS Innovations International plans to expand the global presence of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions.

About SSI Mantra
The SSI Mantra Surgical Robotic System, by SS Innovations International Inc., is a modular multi-arm system with many advanced technology features. It allows for the use of 3-5 robotic arms, has an open-faced ergonomic Surgeon Command Centre, 32-inch large 3D 4K monitor, a 23-inch 2D Touch panel monitor for all patient related information display, a virtual real-time image of the robotic Patient Side Arm Carts, and the ability for superimposition of 3D models of diagnostic imaging. The Vision Cart gives the table-side team the same magnified 3D 4K view as the Surgeon to provide better safety and efficiency. The modular robotic arms give flexibility in positioning and the number of arms to be used. This allows for collision-free conduct of surgical operations. There are over 40 different types of robotic endo-surgical instruments that can be used for different specialties including Cardiac Surgery. The learning curve is short due to its very thoughtful and ergonomic design and user-friendly features.

Share
Written by
Satata Karmakar

Satata Karmakar is a health journalist and Editor of HealthWireMedia.com, with over 12 years of experience in journalism, investigative reporting, newsroom editing and healthcare news.As Editor of HealthWire Media, Satata focuses on delivering accurate, evidence-based and accessible health journalism that helps readers make sense of complex medical and healthcare developments. She specialises in translating medical research, clinical findings, public-health updates and healthcare regulations into clear, engaging stories for healthcare professionals and the wider public.Her areas of coverage include public health, medical research, disease prevention, healthcare policy, health technology, medical education and regulatory developments. She places particular emphasis on verifying health claims through peer-reviewed research, official government notifications, expert interviews and credible institutional sources, including the National Medical Commission (NMC).She is committed to responsible health reporting that prioritises accuracy, context and transparency—especially when covering emerging research, medical breakthroughs, health risks and treatment-related information. Her editorial approach aims to make reliable health information understandable without oversimplifying science or overstating medical claims.Through her work, she seeks to strengthen public understanding of healthcare issues and contribute to informed conversations around health, medicine and policy.Outside the newsroom, Satata enjoys reading and painting, pursuits that continue to inspire her curiosity, creativity and storytelling.

Don't Miss

pneumonia
Health NewsHealth TipsVirus & Disease

World Pneumonia Day 2026: 5 Things You Should Know About This Potentially Serious Lung Infection

A cough, fever or difficulty in breathing may sometimes be more than just a seasonal illness. It could be a sign of pneumonia,...

Health TipsLifestyle & WellnessWellness

Always Tired Despite Getting Enough Sleep? Your Body May Be Trying to Tell You Something

Getting seven to nine hours of sleep every night but still waking up exhausted? Feeling sleepy throughout the day, struggling to concentrate or...

Ebola Outbreak 2026: 11,000 Cases Reported – Should India Worry?
International News

Ebola Outbreak Crosses 11,000 Cases: Should India Worry As Virus Spreads Beyond Congo?

Ebola Outbreak In Congo: The Ebola outbreak in the Democratic Republic of the Congo (DRC) has crossed 11,000 confirmed cases, raising concerns about...

Health TipsLatest NewsVirus & Disease

World Diabetes Day 2026: Can High Blood Sugar Quietly Damage Your Kidneys?

Diabetes and hypertension are two of the most common non-communicable diseases in the world and both of them are the leading causes of...

Stopping GLP-1 Drugs May Double Heart Attack and Stroke Risk
CardiologyHealth News

Stopping GLP-1 Diabetes Medication May Double the Risk of Heart Attack, Stroke and Death, Study Finds

People with type 2 diabetes who stop taking GLP-1 medicines may face a significantly higher risk of serious health problems, including heart attack,...

Section title

Related Articles
Press Release

Sir Ganga Ram Hospital Performs Endoscopic Migraine Surgery, Offers Relief to Patient After a Decade of Chronic Pain

New Delhi: Sir Ganga Ram Hospital has performed advanced endoscopic migraine surgery...

Mosquito Repellent
Press Release

19-Month-Old Recovers After Mosquito Repellent Aspiration

New Delhi: A 19-month-old child was admitted to Sir Ganga Ram Hospital...

Press Release

Complex Hip Replacement with 3D Implant at SGRH

New Delhi: In a landmark medical achievement, Sir Ganga Ram Hospital has...

Sir ganga ram hospital (SGRH)
Press Release

Sir Ganga Ram Hospital Celebrates 71st Founder’s Day; Delhi LG Shri Taranjit Singh Sandhu Graces the Occasion

New Delhi: Sir Ganga Ram Hospital celebrated its 71st Founder’s Day with...